1. Home
  2. IMNM vs KRO Comparison

IMNM vs KRO Comparison

Compare IMNM & KRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • KRO
  • Stock Information
  • Founded
  • IMNM 2006
  • KRO 1916
  • Country
  • IMNM United States
  • KRO United States
  • Employees
  • IMNM N/A
  • KRO N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • KRO Major Chemicals
  • Sector
  • IMNM Health Care
  • KRO Industrials
  • Exchange
  • IMNM Nasdaq
  • KRO Nasdaq
  • Market Cap
  • IMNM 806.1M
  • KRO 903.0M
  • IPO Year
  • IMNM 2020
  • KRO N/A
  • Fundamental
  • Price
  • IMNM $6.73
  • KRO $7.48
  • Analyst Decision
  • IMNM Strong Buy
  • KRO Hold
  • Analyst Count
  • IMNM 5
  • KRO 3
  • Target Price
  • IMNM $26.60
  • KRO $12.00
  • AVG Volume (30 Days)
  • IMNM 1.0M
  • KRO 206.4K
  • Earning Date
  • IMNM 03-19-2025
  • KRO 03-06-2025
  • Dividend Yield
  • IMNM N/A
  • KRO 2.68%
  • EPS Growth
  • IMNM N/A
  • KRO N/A
  • EPS
  • IMNM N/A
  • KRO 0.75
  • Revenue
  • IMNM $9,041,000.00
  • KRO $1,887,100,000.00
  • Revenue This Year
  • IMNM N/A
  • KRO $18.33
  • Revenue Next Year
  • IMNM $476.80
  • KRO $6.63
  • P/E Ratio
  • IMNM N/A
  • KRO $9.96
  • Revenue Growth
  • IMNM N/A
  • KRO 13.24
  • 52 Week Low
  • IMNM $6.41
  • KRO $7.17
  • 52 Week High
  • IMNM $24.87
  • KRO $14.50
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 29.57
  • KRO 33.88
  • Support Level
  • IMNM $6.94
  • KRO $7.61
  • Resistance Level
  • IMNM $7.68
  • KRO $7.94
  • Average True Range (ATR)
  • IMNM 0.55
  • KRO 0.22
  • MACD
  • IMNM -0.15
  • KRO 0.03
  • Stochastic Oscillator
  • IMNM 10.39
  • KRO 28.21

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.

About KRO Kronos Worldwide Inc

Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.

Share on Social Networks: